Research and Markets (http://www.researchandmarkets.com/research/btk4fw/chemotherapy) has announced the addition of the "Chemotherapy Induced Anemia-Pipeline Insights, 2014" subscription to their offering.
This Chemotherapy Induced Anemia-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Chemotherapy Induced Anemia.
This report provides information on the therapeutic development based on the Chemotherapy Induced Anemia dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.
The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Chemotherapy Induced Anemia Overview
- Chemotherapy Induced Anemia Pipeline Therapeutics
- Chemotherapy Induced Anemia Therapeutics under Development by Companies
- Chemotherapy Induced Anemia Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Chemotherapy Induced Anemia Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Chemotherapy Induced Anemia Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Chemotherapy Induced Anemia Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Chemotherapy Induced Anemia - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Chemotherapy Induced Anemia - Discontinued Products
- Chemotherapy Induced Anemia - Dormant Products
- Companies Involved in Therapeutics Development for Chemotherapy Induced Anemia
- Appendix
For more information visit http://www.researchandmarkets.com/research/btk4fw/chemotherapy